在MECP2基因转移中临床前的里程碑用于治疗雷特综合征
Indumathy Jagadeeswaran1, Jiyoung Oh2, Sarah E Sinnett2,3,4
1Department of Pediatrics, The University of Texas Southwestern Medical Center (UTSWMC), Dallas, Texas, USA, indumathy2311@gmail.com.
Developmental neuroscience
|May 9, 2024
概括
雷特综合征 (RTT) 的基因治疗已经从早期研究发展到临床试验,重点是调节的甲基-CpG结合蛋白2 (MECP2) 表达. 这种治疗神经发育障碍的进步是一个重要的里程碑.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 基因治疗 基因治疗
背景情况:
- 雷特综合征 (RTT) 是一种神经发育障碍,源于甲基-CpG结合蛋白2 (MECP2) 基因的突变.
- 在小鼠基因转移后,调节外源MECP2表达至关重要,以防止剂量依赖性毒性.
研究的目的:
- 审查Rett综合征临床前基因疗法的进展情况.
- 为突出开发更安全,受管制的MECP2病毒基因组设计.
- 承认在推进RTT基因疗法的国际合作.
主要方法:
- 对雷特综合征的临床前基因治疗文献的审查.
- 分析了MECP2病毒基因组设计的演变.
- 追踪从最初出版到临床管理的时间表.
主要成果:
- 针对RTT的临床前基因疗法已经通过概念验证研究推进到受调节的MECP2基因设计.
- 国际合作是这一进展的关键.
- 针对RTT的研究性基因疗法于2023年给患者使用.
结论:
- 对RTT的基因治疗的发展表明,朝着更安全,更有效的治疗方法的努力进展.
- 第一个临床管理代表了RTT研究的共同里程碑.
- 未来的研究很可能会关注有关MECP2基因转移安全性,有效性和机制的细微假设.
相关概念视频
Gene Conversion
Other than maintaining genome stability via DNA repair, homologous recombination plays an important role in diversifying the genome. In fact, the recombination of sequences forms the molecular basis of genomic evolution. Random and non-random permutations of genomic sequences create a library of new amalgamated sequences. These newly formed genomes can determine the fitness and survival of cells. In bacteria, homologous and non-homologous types of recombination lead to the evolution of new...
Non-LTR Retrotransposons
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...


